118 related articles for article (PubMed ID: 38522961)
1. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center.
Díaz-Gavela AA; Cerro Peñalver ED; Sanchez-Garcia S; Pardo-Perez E; Thuissard-Vasallo IJ; Andreu-Vázquez C; Molina López MY; Pena Huertas M; Guerrero-Gómez LL; Sanz-Rosa D; Lorenzo FC
Brachytherapy; 2024; 23(3):342-354. PubMed ID: 38522961
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
4. Thermal boost combined with interstitial brachytherapy in breast conserving therapy - Assessment of early toxicity.
Chicheł A; Skowronek J; Kanikowski M
Rep Pract Oncol Radiother; 2011; 16(3):87-94. PubMed ID: 24376963
[TBL] [Abstract][Full Text] [Related]
5. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
8. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.
Resch A; Pötter R; Van Limbergen E; Biber E; Klein T; Fellner C; Handl-Zeller L; Langbauer G; Schürer-Waldheim H; Staffen A; Jakesz R; Kubista E; Lehr S; Seitz W
Radiother Oncol; 2002 Apr; 63(1):47-58. PubMed ID: 12065103
[TBL] [Abstract][Full Text] [Related]
9. 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment.
Quéro L; Guillerm S; Taright N; Michaud S; Teixeira L; Cahen-Doidy L; Bourstyn E; Espié M; Hennequin C
Radiother Oncol; 2017 Jan; 122(1):11-16. PubMed ID: 27474504
[TBL] [Abstract][Full Text] [Related]
10. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
[TBL] [Abstract][Full Text] [Related]
11. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
12. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
13. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer F; Zehentmayr F; Fastner G
Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
[TBL] [Abstract][Full Text] [Related]
14. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.
Arthur DW; Koo D; Zwicker RD; Tong S; Bear HD; Kaplan BJ; Kavanagh BD; Warwicke LA; Holdford D; Amir C; Archer KJ; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):681-9. PubMed ID: 12788173
[TBL] [Abstract][Full Text] [Related]
15. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
16. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
[TBL] [Abstract][Full Text] [Related]
17. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
18. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
19. Thermally boosted interstitial high-dose-rate brachytherapy in high-risk early-stage breast cancer conserving therapy - large cohort long-term results.
Chicheł A; Burchardt WM; Kluska A; Chyrek AJ
Rep Pract Oncol Radiother; 2023; 28(5):661-670. PubMed ID: 38179295
[TBL] [Abstract][Full Text] [Related]
20. Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancer.
Sharma DN; Deo SV; Rath GK; Shukla NK; Thulkar S; Madan R; Julka PK
Tumori; 2013; 99(5):604-10. PubMed ID: 24362865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
